California Nanotechnologies is trading 8.8% down at $0.24 as investors digest its Q1 2027 financial results, announced around July 30, 2026.
- The company reported a 28% increase in revenue to US$917,854, but net loss remained essentially flat at US$449,598, and adjusted EBITDA loss narrowed.
- Growth was largely driven by a one-time equipment sale, not sustained manufacturing services, with gross margin compression and ongoing customer concentration risk contributing to investor concerns.